Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC; Radiation: Stereotactic Body Radiation Therapy (SBRT) Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials